STarting incrEmental Prescription of Peritoneal Dialysis
Recruiting
N/A
Interventional Study
Peritoneal Dialysis (PD)
Kidney Failure
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 224 (estimated)
- Sponsor
- The University of Queensland · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Kidney failure is fatal without dialysis. Peritoneal dialysis (PD) completed at home offers greater flexibility and autonomy for patients . However, PD is often prescribed for 24 hours/day, 7 days/week for every patient starting dialysis. This practice is not evidence-informed, may be unnecessary and potentially harmful. The STEP-PD trial aims to determine the optimal approach to commencing patien…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* adults (≥18 years) commencing PD as their first dialysis therapy (and been on dialysis for \<1 month)
* able to give informed consent
Exclusion Criteria:
* urine output \<0.5L/day
* previous kidney transplant
* unlikely to be on dialysis for ≥1 year.
* known or planned pregn…
Contacts